Show simple item record

Increase in CD5+ B Cells in Juvenile Rheumatoid Arthritis

dc.contributor.authorJarvis, James N.en_US
dc.contributor.authorKaplan, Josephen_US
dc.contributor.authorFine, Nancyen_US
dc.date.accessioned2006-04-28T16:24:43Z
dc.date.available2006-04-28T16:24:43Z
dc.date.issued1992-02en_US
dc.identifier.citationJarvis, James N.; Kaplan, Joseph; Fine, Nancy (1992)."Increase in CD5+ B Cells in Juvenile Rheumatoid Arthritis." Arthritis & Rheumatism 35(2): 204-207. <http://hdl.handle.net/2027.42/37790>en_US
dc.identifier.issn0004-3591en_US
dc.identifier.issn1529-0131en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/37790
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1370899&dopt=citationen_US
dc.description.abstractObjective. To investigate the association between CD5+ B cell expression and IgM rheumatoid factor (IgM-RF) in juvenile rheumatoid arthritis (JRA). Methods. CD5+ B cell levels analyzed by flow cytometry and IgM-RF expression determined by enzymelinked immunosorbent assay were compared in children with JRA, children with other collagen vascular diseases, and healthy controls. Results. Children with polyarticular JRA had expanded populations of CD5+ B cells, and expansion of CD5+ B cells and IgM-RF both correlated with disease activity. Conclusion. The results indicate that an expanded CD5+ B cell population leads to IgM-RF production in patients with polyarticular JRA, as well as patients with RA.en_US
dc.format.extent381372 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherJohn Wiley & Sons, Inc.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherRheumatologyen_US
dc.titleIncrease in CD5+ B Cells in Juvenile Rheumatoid Arthritisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherDepartment of Pediatrics, the Division of Rheumatology, and the Division of Tumor Immunology, Wayne State University School of Medicine, and the Children's Hospital of Michigan, Detroit. ; Department of Immunology and Rheumatology, Children's Hospital of Michigan, 3901 Beaubien Boulevard, Detroit, MI 48201en_US
dc.contributor.affiliationotherDepartment of Pediatrics, the Division of Rheumatology, and the Division of Tumor Immunology, Wayne State University School of Medicine, and the Children's Hospital of Michigan, Detroit.en_US
dc.contributor.affiliationotherDepartment of Pediatrics, the Division of Rheumatology, and the Division of Tumor Immunology, Wayne State University School of Medicine, and the Children's Hospital of Michigan, Detroit.en_US
dc.identifier.pmid1370899en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/37790/1/1780350213_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/art.1780350213en_US
dc.identifier.sourceArthritis & Rheumatismen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.